Evolving trends in reverse shoulder arthroplasty

This issue of Annals of Joint that I have had the pleasure to guest edit, is truly focused on the revolutionary effects of reverse shoulder arthroplasty on the orthopedic patient in 2019. We have been lucky enough to assimilate leading authors from around the world to help shed insight and highlight the current practice patterns around reverse shoulder arthroplasty (both the primary and revision setting). It is remarkable to think that this revolutionary technology 15 years ago was not available in the United States. It is now at the forefront of treatment options for patients with irreparable rotator cuff tears, severe arthritis, comminuted proximal humerus fractures, and various other complex reconstructive indications. It is an honor to have been able to guest edit this Journal issue. I am particularly grateful to my tremendous group of co-authors who have volunteered their time and expertise to make this truly a comprehensive and essential reference issue for all shoulder surgeons to have access to. I also want to thank my family for allowing me the time to devote to this issue. We hope you enjoy what we have prepared for you and help us in our ongoing initiative to improve the quality of shoulder care around the world.

Acknowledgments

I would like thank all the authors who contributed to this issue. I would also like to specifically thank my wife Soo for her endless support and my two wonderful children Margo and Joey for the joy they add to each day.

Funding: None

Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Joint for the series “Evolving Trends in Reverse Shoulder Arthroplasty”. The article did not undergo external peer review.

Conflict of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/aoj.2019.01.08). The series “Evolving Trends in Reverse Shoulder Arthroplasty” was commissioned by the editorial office without any funding or sponsorship. JAA reports other from Aevumed, non-financial support from Arthrex, personal fees from Cayenne, other from Curical Technologies LTD, non-financial support from DePuy Synthes, non-financial support from Department of Defense, personal fees from DJO, personal fees from Globus, personal fees and non-financial support from Integra, other from Marlin Medical Alliance, LLC, other from Mid Atlantic Shoulder and Elbow Society, other from Mininvasive, other from OBERD, non-financial support from OREF, non-financial support from Orthospace, other from Shoulder JAM LLC, personal fees from SLACK, personal fees from Stryker, personal fees and non-financial support from Tornier, personal fees from Wolter Kluwer Health-Lippincott Williams and Wilkins, non-financial support from Zimmer Biomet, outside the submitted work; In addition, Dr. Abboud has a patent Shoulder Implant Components with royalties paid to Encore Medical, LP, and a patent Shoulder Implant Component; Glenoid with royalties paid to Encore Medical, LP. JAA served as the unpaid Guest Editor of the series and serves as an unpaid editorial board member of Annals of Joint from Apr 2018 to May 2019. The author has no other conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Joseph A. Abboud